The document discusses Johnson & Johnson's corporate ethics, highlighting both its adherence to its credo prioritizing customer health and its legal issues related to off-label drug marketing. It also touches on corporate social responsibility rhetoric versus reality, and the influence of corporations in regulatory environments.
doj/DataSet10/EFTA01378458.pdf
{"key_people":["Lisa Hope Nicholson","Olaf Weber","Marco Mansfeld","Eric Schirrmann","Claire A. Hill","Lisa Fairfax"],"document_type":"correspondence","document_subtype":"legal analysis","key_organizations":["Johnson & Johnson","Department of Justice","University of Chicago","Fortune 100","Domini 400 Social Index"],"reference_numbers":["n37","n38","n39","n40"]}